| Home |
| Business |
| Sciences |
| Regulatory & IPR |
| Market Studies |
| Open Source |
| News in Brussels |
| Technological partnership |
| European opportunities |
| IPR Support |
| Strategic Information |
| Bio&Pharma e-Newsletter |
| Legal note |
| Bio&Pharma Companies |
| Bio&Pharma Universities |
| Bio&Pharma Organisations |
| BEA-ABE-BAO |
| MedTech Universities |
| MedTech Organisations |
| MedTech Companies |
Tuesday, 22 June 2010
EU-funded scientists have discovered new genes involved in determining human eye colour. More than just blue, green and brown, the team believes that our eye colour has many more dimensions and variations than previously documented. This new lead has the potential to be used in forensic science, providing investigators with a 'face' to genetic clues left at a crime scene. Findings from the study are published in the journal PLoS (Public Library of Science) Genetics.
Led by the Erasmus University Medical Center in the Netherlands,
the researchers uncovered three new genetic loci (the locations of gene
sequences on chromosomes) that significantly contribute to the natural
and subtle eye colour variations that distinguish one person from the
next.
Learning about the role of the three loci (referred to as LYST,
17q25.3, and TTC3/DSCR9) has added to a more comprehensive and concise
understanding of the genetic basis of human eye colour. With the new
knowledge generated by the team, we now know more than half of the
attributes in eye colour variance. Although the LYST gene had
previously been acknowledged as a pigmentation gene in mice and cattle,
no association with pigmentation had ever been made to the other two
genes prior to this study.
Summarising the results in their published paper, the scientists
write: 'Our quantitative prediction model explained over 50% of eye
colour variance, representing the highest accuracy achieved so far in
genomic prediction of human complex and quantitative traits, with
relevance for future forensic applications.'
The genome-wide study involving almost 6,000 Dutch Europeans (and a
further 3,500 individuals from Australia and the UK for study
replication) was the first ever to be conducted on quantitative human
eye colour. Their novel approach was to measure hue and saturation
values of eye colour from high-resolution digital, full-eye
photographs.
The approach was so effective that the researchers recommend fine
phenotyping as a useful strategy for finding genes involved in human
complex traits, highlighting the method as being extremely cost
effective, portable and time efficient.
Indeed, it was due to the fine phenotyping approach that the
scientists found that variation in human eye colour is a constant
(unbroken) grading from the lightest shade of blue to the darkest shade
of brown or black. For the team, human eye colour varies in more ways
than the one represented by the blue, green and brown categories
studied in the past.
Dr Manfred Kayser of the Erasmus University Medical Center
referenced the remarkable potential of the research results in helping
with criminal and forensic investigations, 'where appearance prediction
from biological material found at crime scenes may provide
investigative leads to trace unknown persons'.
In addition to researchers from several departments within Erasmus
University Medical Center, the project included teams from the
University of Cologne in Germany, King's College London in the UK, and
Australia's Queensland Institute of Medical Research and University of
Western Australia.
The research was supported by the GEFOS ('Genetic factors for
osteoporosis') and ENGAGE ('European network for genetic and genomic
epidemiology') projects, which received a total of EUR 15 million in
funding under the Health Theme of the EU's Seventh Framework Programme
(FP7).
The MY EUROPIA ('European training in myopia research') Marie Curie
Research Training Network, which received EUR 3.17 million under the
EU's Sixth Framework Programme (FP6), and the GENOMEUTWIN ('Studies of
European volunteer twins to identify genes underlying common diseases')
project, supported under the 'Quality of Life and Management of the
Living Resources' programme of the EU's Fifth Framework Programme (FP5)
also contributed to the study.
Source: Cordis